These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
|
Preliminary Proxy Statement
|
|
|
|
|
|
¨
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
|
x
|
|
Definitive Proxy Statement
|
|
|
|
|
|
¨
|
|
Definitive Additional Materials
|
|
|
|
|
|
¨
|
|
Soliciting Material Pursuant to §240.14a-12
|
|
|
|
|
|
|
|
|
|
|||
|
x
|
|
No fee required.
|
||
|
|
|
|||
|
¨
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|
|
|
||
|
|
|
(1)
|
|
Title of each class of securities to which the transaction applies:
|
|
|
|
(2)
|
|
Aggregate number of securities to which the transaction applies:
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5)
|
|
Total fee paid:
|
|
|
|
|||
|
¨
|
|
Fee paid previously with preliminary materials.
|
||
|
|
|
|||
|
¨
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
|
|
||
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
(4)
|
|
Date Filed:
|
|
|
|
|
|
Victor Mandel
Co-Chairman |
Nader Tavakoli
Co-Chairman |
Diana N. Adams
Chief Executive Officer |
|
Time and Date
|
12:00 p.m. (Eastern) on May 22, 2014
|
||
|
Place
|
Ambac Financial Group, Inc.
One State Street Plaza, 16
th
Floor
New York, New York 10004
|
||
|
Items of Business
|
(1) To elect five members of the Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
|
||
|
|
(2) To ratify the appointment of KPMG as Ambac’s independent registered public accounting firm for the fiscal year ending December 31, 2014.
|
||
|
|
(3) To approve, on an advisory basis, the compensation of our named executive officers.
|
||
|
|
|
||
|
Adjournments and Postponements
|
Any action on the items of business described above may be considered at the Annual Meeting at the time and on the date specified above or at any time and date to which the Annual Meeting may be properly adjourned or postponed.
|
||
|
Record Date
|
You are entitled to vote only if you were an Ambac stockholder as of the close of business on March 26, 2014 (“Record Date”). You will need proof of ownership of our common stock to enter the meeting.
|
||
|
Voting
|
Your vote is very important. Whether or not you plan to attend the Annual Meeting, we encourage you to read this Proxy Statement and submit your proxy or voting instructions as soon as possible. For specific instructions on how to vote your shares, please refer to the instructions on the Notice Regarding the Availability of Proxy Materials
(“Internet Notice”) you received in the mail, the section titled “Information About the Annual Meeting and Voting” beginning on page 1 of this Proxy Statement or, if you requested to receive printed proxy materials, your enclosed proxy or voting instruction card.
|
||
|
|
By order of the Board of Directors,
|
||
|
|
William J. White
Corporate Secretary
|
||
|
|
|
|
|
|
•
|
Our Proxy Statement for the 2014 Annual Meeting of Stockholders;
|
|
•
|
Our 2013 Annual Report to Stockholders, which includes our Annual Report on Form 10-K for the fiscal year ended December 31, 2013; and
|
|
•
|
The proxy card or a voting instruction card for the Annual Meeting.
|
|
•
|
View our proxy materials for the Annual Meeting on the internet and vote your shares; and
|
|
•
|
Instruct us to send our future proxy materials to you electronically by email.
|
|
•
|
The election of five directors.
|
|
•
|
The ratification of the appointment of KPMG LLP as Ambac’s independent registered public accounting firm for the fiscal year ending December 31, 2014.
|
|
•
|
To approve, on an advisory basis, the compensation of our named executive officers.
|
|
•
|
“FOR” each of the nominees to the Board of Directors.
|
|
•
|
“FOR” the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the 2014 fiscal year.
|
|
•
|
“FOR”, the approval, on an advisory basis, of the compensation of our named executive officers.
|
|
•
|
As necessary to meet applicable legal requirements;
|
|
•
|
To allow for the tabulation and certification of votes; and
|
|
•
|
To facilitate a proxy solicitation.
|
|
(1)
|
the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014; and
|
|
(2)
|
advisory vote on the compensation of our named executive officers.
|
|
Name
|
Age
|
Position with Ambac
|
|
|
Diana N. Adams
|
51
|
Chief Executive Officer and Director
|
|
|
Victor Mandel
|
49
|
Co-Chair of the Board of Directors
|
|
|
Nader Tavakoli
|
56
|
Co-Chair of the Board of Directors
|
|
|
Eugene M. Bullis
|
68
|
Director
|
|
|
Jeffrey S. Stein
|
44
|
Director
|
|
|
•
|
Selecting and approving fees and terms of auditors’ engagement.
|
|
•
|
Approving the audit and non-audit services to be performed by our independent auditors.
|
|
•
|
Evaluating the experience, performance, qualifications, and independence of our independent auditors.
|
|
•
|
Reviewing the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters.
|
|
•
|
Reviewing the design, operation and effectiveness of our internal controls and our critical accounting policies.
|
|
•
|
Reviewing with management our annual audited financial statements, quarterly financial statements, earnings and any other material press releases related to accounting or financial matters announcements.
|
|
•
|
Review and approve the committee report the SEC requires for inclusion in our annual proxy statement.
|
|
•
|
Reviewing our Regulation FD Policy.
|
|
•
|
Establishing procedures for the confidential and anonymous receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters.
|
|
•
|
Reviewing the overall compensation principles governing the compensation and benefits of the executive officers and other employees.
|
|
•
|
Evaluating the performance of our Chief Executive Officer.
|
|
•
|
Reviewing the procedures for the evaluation of the non-CEO executive officers.
|
|
•
|
Reviewing and approving the selection of our peer companies to use as a reference in determining competitive compensation packages.
|
|
•
|
Determining all executive officer compensation (including but not limited to salary, bonus, incentive compensation, equity awards, benefits and perquisites).
|
|
•
|
Reviewing and approving the terms of any employment agreements and severance arrangements, change-in-control agreements, and any special or supplemental compensation and benefits for the executive officers and individuals who formerly served as executive officers.
|
|
•
|
Acting as the administering committee for our stock and bonus plans and for any equity compensation arrangements that may be adopted by us from time to time.
|
|
•
|
Making and approving grants of options and other awards to directors under Ambac’s compensation plans.
|
|
•
|
Reviewing and discussing with management the annual Compensation Discussion and Analysis (CD&A) disclosure, when applicable, and, based on this review and discussion, making a recommendation to include the CD&A disclosure in our annual public filings, when applicable.
|
|
•
|
Preparing the annual Compensation Committee Report for inclusion in our annual public filings.
|
|
•
|
Evaluating the composition, size, organization, and governance of our Board of Directors and its committees, determining future requirements, and making recommendations regarding future planning, the appointment of directors to our committees, and the selection of chairs of these committees.
|
|
•
|
Periodically reviewing the standards for director independence and provide the Board with an assessment of which directors should be deemed independent.
|
|
•
|
Determining the criteria for Board membership.
|
|
•
|
Evaluating the participation of members of the Board in continuing education.
|
|
•
|
Reviewing and recommending to our Board of Directors the compensation of our non-employee directors and our subsidiaries’ directors.
|
|
•
|
Reviewing plans for the succession of our executive officers.
|
|
•
|
Reviewing and approving related party transactions.
|
|
•
|
Administering a procedure to consider stockholder recommendations for director nominees.
|
|
•
|
Evaluating and recommending candidates for election or re-election to our Board of Directors, including nominees recommended by stockholders.
|
|
•
|
Reviewing periodically Ambac’s Code of Business Conduct and compliance therewith.
|
|
•
|
Overseeing Ambac’s risk management framework, including significant policies and practices for managing risk exposure.
|
|
•
|
Reviewing with management Ambac’s loss mitigation and remediation strategies and processes.
|
|
•
|
Consulting with the Audit Committee on key guidelines and policies for risk assessment and risk management.
|
|
•
|
Oversight of capital structure, financing and treasury matters.
|
|
•
|
Reviewing, evaluating and recommending to the Board the proposed terms of certain financing activities that require Board approval.
|
|
•
|
Reviewing Ambac’s short-term and long-term financial and investment guidelines, plans and strategies.
|
|
•
|
Reviewing and making recommendations to the Board regarding strategic plans and initiatives, including potential material investments in joint ventures, mergers, acquisitions, and other business combinations.
|
|
Name
|
Fees
Earned or Paid in Cash ($) |
Stock Awards
(1)
($)
|
Option Awards
(2)
($)
|
All Other Compensation
(3)
($) |
Total
($)
|
|
Eugene M. Bullis
|
$225,000
|
$375,033
|
$125,003
|
-
|
$725,036
|
|
Victor Mandel
|
$225,000
|
$375,033
|
$125,003
|
-
|
$725,036
|
|
Jeffrey S. Stein
|
$225,000
|
$375,033
|
$125,003
|
-
|
$725,036
|
|
Nader Tavakoli
|
$225,000
|
$375,033
|
$125,003
|
-
|
$725,036
|
|
1.
|
The value of the restricted stock units (“RSUs”) reported in the table above is based on the grant date fair value of awards computed in accordance with FASB ASC Topic 718. See Note 17 of Notes to the Consolidated Financial Statements contained in our 2013 Annual Report on Form 10-K for a discussion of the assumptions used in the valuation of the RSUs. The total number of RSUs held by each of the non-employee directors as of December 31, 2013 was as follows: Mr. Bullis, 18,179; Mr. Mandel, 18,179; Mr. Stein, 18,179; and Mr. Tavakoli, 18,179.
|
|
2.
|
The value of the stock options reported in the table above is based on the grant date fair value of stock options computed in accordance with FASB ASC Topic 718. See Note 17 of Notes to the Consolidated Financial Statements contained in our 2013 Annual Report on Form 10-K for a discussion of the assumptions used in the valuation of the stock options. The total number of stock options held by each of the non-employee directors as of December 31, 2013 was as follows: Mr. Bullis, 16,667; Mr. Mandel, 16,667; Mr. Stein, 16,667; and Mr. Tavakoli, 16,667.
|
|
3.
|
Prior to their formal appointment to the Board of Directors on May 1, 2013, Messrs. Mandel, Stein and Tavakoli were each paid $30,000 by Ambac in 2013 pursuant to a consulting agreement dated as of July 12, 2012 among each of them, Ambac and the Official Committee of Unsecured Creditors of Ambac.
|
|
Name
|
Fees
Earned or Paid in Cash ($) (1) |
|
All Other Compensation
($) (2) |
|
Total
($)
|
|
|||
|
Michael Callen
|
|
$87,500
|
|
|
$10,971
|
|
|
$98,471
|
|
|
Jill M. Considine
|
|
$37,000
|
|
-
|
|
|
$37,000
|
|
|
|
Paul R. DeRosa
|
|
$37,000
|
|
-
|
|
|
$37,000
|
|
|
|
Philip N. Duff
|
|
$46,167
|
|
|
$10,971
|
|
|
$57,138
|
|
|
Thomas C. Theobald
|
|
$45,333
|
|
|
$781
|
|
|
$46,114
|
|
|
Laura S. Unger
|
|
$45,333
|
|
|
$10,971
|
|
|
$56,304
|
|
|
Henry D.G. Wallace
|
|
$50,333
|
|
-
|
|
|
$50,333
|
|
|
|
David W. Wallis
|
|
$32,500
|
|
|
$10,971
|
|
|
$43,471
|
|
|
(1)
|
This column reflects the pro-rated annual retainer fee of $30,000 received by each of our Pre-Emergence non-employee directors for the first four months of 2013. In addition, Ambac paid a fee of (i) $1,500 for attendance at each committee meeting and $2,500 for attendance at each Ambac or Ambac Assurance Board of Directors meeting; and, (ii) $6,667 for chairing the Audit and Risk Assessment Committee, $3,333 for chairing either the Governance Committee or the Compensation Committee and $8,333 for acting as presiding director, in each case, for the first four months of 2013. Thus, in addition to the pro-rated annual retainer fee described above, each Pre-Emergence non-employee director also received the following:
|
|
•
|
Michael A. Callen earned a fee of $50,000 for his role as Non-Executive Chairman of Ambac and Ambac Assurance. Mr. Callen also earned a total fee of $7,500 for his attendance at Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Jill Considine earned $7,000 for her attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Paul DeRosa earned $7,000 for his attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Philip Duff earned a fee of $6,667 for his role as Chairman of the Audit and Risk Assessment Committee. Mr. Duff also earned $9,500 for his attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Thomas Theobald earned $3,333 for his role as Chairman of the Compensation Committee. Mr. Theobald also earned $12,000 for his attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Laura Unger earned $3,333 for her role as Chairman of the Governance Committee. Ms. Unger also received $12,000 for her attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
Henry D. G. Wallace earned a fee of $8,333 for his role as Presiding Director. Mr. Wallace also received $12,000 for his attendance at committee and Board meetings held between January 1, 2013 and May 1, 2013.
|
|
•
|
David W. Wallis earned a fee of $2,500 for his attendance at Ambac’s Board meetings held between January 1, 2013 and May 1, 2013.
|
|
(2)
|
The amounts shown include premiums that Ambac has paid in connection with the medical insurance that it provides to the following directors: Mr. Callen: $10,971, Mr. Duff: $10,971, Mr. Theobald: $781, Ms. Unger $10,971 and Mr. Wallis: $10,971.
|
|
•
|
Each person whom we know beneficially owns more than 5% of our common stock.
|
|
•
|
Each of our directors and nominees for the Board of Directors.
|
|
•
|
Each of our named executive officers (see the section titled “Executive Compensation”).
|
|
•
|
All of our directors and executive officers as a group.
|
|
|
Amount and Nature of Shares Beneficially Owned
|
|
|
Name
|
Number (1)
|
Percent of
Class (2) |
|
|
|
|
|
Executive Officers and Directors
|
|
|
|
Diana N. Adams
|
16,564
|
*
|
|
Robert B. Eisman
|
4,740
|
*
|
|
David Trick
|
11,850
|
*
|
|
Eugene M. Bullis
|
34,846
|
*
|
|
Victor Mandel
|
34,846
|
*
|
|
Jeffrey S. Stein
|
34,846
|
*
|
|
Nader Tavakoli
|
34,846
|
*
|
|
All executive officers and directors as a group (12 persons)
|
179,649
|
*
|
|
1.
|
For each of the named executive officers, their share ownership in this column includes restricted stock units (“RSUs”), which vested on December 20, 2013, but shall not settle and convert into shares of common stock until the earlier of (a) the named executive officer’s termination of employment with the Company (other than with respect to a termination for “cause”) or (b) December 20, 2015, as follows: Ms. Adams, 16,564 RSUs; Mr. Eisman, 4,740 RSUs; and Mr. Trick, 11,850 RSUs. For each of Messrs. Bullis, Mandel, Stein, and Tavakoli (the “Independent Directors”), their share ownership in this column includes RSUs and stock options, which will vest on April 30, 2014. The RSUs granted to each of the Independent Directors shall not settle and convert into shares of common stock until such director resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Each RSU represents a contingent right to receive one share of the Company’s common stock. RSUs granted to our named executive officers, and RSUs and stock options granted to the Independent Directors, that vest more than
|
|
2.
|
Applicable percentage ownership is based on 45,002,575 shares of common stock outstanding at March 26, 2014. In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, we deemed outstanding shares of common stock subject to options or warrants held by that person that are currently exercisable or exercisable within 60 days of March 26, 2014. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Each holder of common stock is entitled to one vote per share of common stock on all matters submitted to our stockholders for a vote.
|
|
•
|
a “related party” means:
|
|
•
|
a member of the Board of Directors (or a nominee to the Board of Directors);
|
|
•
|
an executive officer;
|
|
•
|
any person who is known by Ambac to be the beneficial owner of more than 5% of our common stock; or
|
|
•
|
any person known by Ambac to be an immediate family member of any of the persons listed above; and
|
|
•
|
a “related transaction” means a transaction (and/or amendment thereto) with a related party occurring since the beginning of our last fiscal year, or any currently proposed transaction, involving Ambac where the amount exceeds $120,000 and in which any related party had or will have a direct or indirect interest.
|
|
•
|
whether the terms of the related party transaction are fair to Ambac and on the same basis as would apply if the transaction did not involve a related party;
|
|
•
|
whether the related party transaction would present an improper conflict of interests for any director or executive officer of Ambac, taking into account the size of the transaction, the overall financial position of the director, executive officer or related party, the direct or indirect nature of the director's, executive officer's or related party's interest in the transaction and the ongoing nature of any proposed relationship, and any other factors the Committee deems relevant.
|
|
Name
|
Age
|
Position with Ambac
|
|
Diana N. Adams
|
51
|
Chief Executive Officer and Director
|
|
David Barranco
|
43
|
Senior Managing Director
|
|
Iain H. Bruce
|
54
|
Senior Managing Director
|
|
Robert B. Eisman
|
46
|
Chief Accounting Officer
|
|
Stephen M. Ksenak
|
48
|
Senior Managing Director and General Counsel
|
|
Cathleen J. Matanle
|
61
|
Senior Managing Director
|
|
Michael Reilly
|
57
|
Senior Managing Director
|
|
David Trick
|
42
|
Chief Financial Officer
|
|
Name and Principal Position
|
Year
|
Salary
($) |
|
Bonus
($) |
|
Stock
Awards ($)(1) |
All Other
Compensation ($)(2) |
|
Total
($) |
|
|
Diana N. Adams,
President and Chief Executive Officer
|
2013
|
800,000
|
|
475,000
|
|
700,000
|
10,200
|
|
1,985,200
|
|
|
2012
|
750,000
|
|
550,000
|
|
0
|
10,000
|
|
1,310,000
|
|
|
|
David Trick
Senior Managing Director, Chief Financial Officer and Treasurer |
2013
|
625,000
|
|
360,000
|
|
500,000
|
10,200
|
|
1,495,200
|
|
|
2012
|
600,000
|
|
425,000
|
|
0
|
10,000
|
|
1,035,000
|
|
|
|
Robert B. Eisman
Senior Managing Director and Chief Accounting Officer
|
2013
|
500,000
|
|
215,000
|
|
200,000
|
10,200
|
|
925,200
|
|
|
2012
|
500,000
|
|
250,000
|
|
0
|
10,000
|
|
760,000
|
|
|
|
(1)
|
The value of restricted stock unit awards is based on the aggregate grant date fair value computed in accordance with
FASB ASC Topic 718
. For a discussion of the assumptions made in the valuation see footnote 17 to Ambac’s consolidated financial statements for the year-ended December 31, 2013.
|
|
(2)
|
“All Other Compensation” represents contributions by Ambac to the Ambac Assurance Savings Incentive Plan.
|
|
Named Executive Officer
|
Number of Restricted Stock
Units That Have Not Vested (1) |
Market Value of Restricted Stock Units That Have Not Vested
|
|
Diana N. Adams
|
16,966
|
$416,685
|
|
David Trick
|
12,119
|
$297,643
|
|
Robert B. Eisman
|
4,848
|
$119,067
|
|
(1)
|
The RSU awards were granted to our named executive officers on December 20, 2013 under the 2013 Incentive Compensation Plan. Each of the RSU agreements provide that the RSUs shall vest in two installments, 50% on the grant date and 50% on the first anniversary of the grant date (each a “Vesting Date”). RSUs that have become vested shall settle and convert into shares of the Company’s common stock on the earlier of (a) the grantee’s termination of employment with the Company (other than with respect to a termination for “cause”) or (b) the second anniversary of the applicable Vesting Date. Notwithstanding the foregoing, a number of vested RSUs sufficient to satisfy any tax withholding obligations imposed upon the Company may be converted into shares of common stock and withheld by the Company to satisfy such tax withholding obligations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
Category |
|
Number of Securities
to be Issued Upon Exercise of Outstanding Options, Warrants and Rights |
|
|
Weighted-Average
Exercise Price of Outstanding Options, Warrants and Rights |
|
|
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the Second Column) |
|
|||
|
Equity compensation plans approved by security holders
|
|
2013 Incentive
Compensation
Plan
(1)
|
|
|
220,854
(2)
|
|
|
|
$20.63
(3)
|
|
|
|
3,779,146
|
|
|
Equity compensation plans not approved by security holders
|
|
None
|
|
|
---
|
|
|
|
---
|
|
|
|
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
220,854
(2)
|
|
|
|
$20.63
(3)
|
|
|
|
3,779,146
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Our 2013 Incentive Compensation Plan was approved by the stockholders of Ambac on December 18, 2013. The total number of shares of Ambac common stock available for issuance under the 2013 Incentive Compensation Plan is 4,000,000.
|
|
(2
|
)
|
Represents
outstanding restricted stock unit awards and stock options, as of December 31, 2013. As of that date, the only grants made under the 2013 Incentive Compensation Plan were in the form of restricted stock unit awards and stock options. See Note 17 to Ambac’s consolidated financial statements in our 2013 Annual Report on Form 10-K for a description of the grants made under the 2013 Incentive Compensation Plan.
|
|
(3
|
)
|
Each
restricted stock unit and each stock option awarded under our 2013 Incentive Compensation Plan was granted at no cost to the persons receiving them. Restricted stock units represent the contingent right to receive the equivalent number of shares of Ambac common stock. Stock options represent the right to acquire an equivalent number of shares of Ambac common stock at a specified exercise price.
|
|
Audit Related Expenses
|
2013
|
|
2012
|
|
||
|
Audit Fees
(1)
|
|
$2,679,252
|
|
|
$2,449,498
|
|
|
Audit Related Fees
(2)
|
77,447
|
|
209,849
|
|
||
|
Tax Fees
(3)
|
59,530
|
|
324,037
|
|
||
|
All Other Fees
(4)
|
—
|
|
—
|
|
||
|
Total
|
|
$2,816,229
|
|
|
$2,983,384
|
|
|
(1)
|
Audit fees consisted of audit work performed in connection with the annual and quarterly financial statements, as well as work generally only the independent auditor can reasonably be expected to provide, such as statutory audits, consents and comfort letters and attest services.
|
|
(2)
|
Audit related fees are for services traditionally performed by the independent auditor, including due diligence related to mergers and acquisitions, employee benefit plan audits, agreed upon procedures and certain consultation regarding financial accounting and/or reporting standards. In 2013 and 2012, these fees consisted principally of audits of employee benefit plans and certain accounting consultations.
|
|
(3)
|
Tax fees consist principally of tax compliance services and tax advice to Ambac and its UK insurance subsidiary.
|
|
(4)
|
Other fees are those associated with services not captured in the other categories. Ambac generally does not request such services from the independent auditor.
|
|
•
|
Diana N. Adams
|
|
•
|
Eugene M. Bullis
|
|
•
|
Victor Mandel
|
|
•
|
Jeffrey S. Stein
|
|
•
|
Nader Tavakoli
|
|
The Board of Directors recommends you vote FOR the following:
1.
Election of Director Nominees:
|
For
All
__
/__
/
|
Withhold
All
__
/__ /
|
For All
Except
__
/__ /
|
To withhold authority to vote for an
individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
_______________________
|
|
01 Diana N. Adams
|
02 Eugene M. Bullis
|
03 Victor Mandel
|
04 Jeffrey S. Stein
|
05 Nader Tavakoli
|
|
The Board of Directors recommends you vote FOR proposals 2 and 3.
|
For
|
Against
|
Abstain
|
|
2.
To ratify the appointment of KPMG as Ambac's independent registered public accounting firm for the fiscal year ending December 31, 2014.
|
__
/__ /
|
__
/__ /
|
__
/__ /
|
|
3.
To approve, on an advisory basis, the compensation for our named executive officers.
|
__
/__ /
|
__
/__ /
|
__
/__ /
|
|
|
Yes
|
No
|
|
Please indicate if you plan to attend this meeting.
|
__
/__ /
|
__
/__ /
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Signature (please sign within Box)
|
|
Date
|
|
Signature (please sign within Box)
|
|
Date
|
|
AMBAC FINANCIAL GROUP, INC.
|
Meeting Information
Meeting Type:
Annual Meeting
For holders as of:
March 26, 2014
Date:
May 22, 2014
Time:
12:00 PM EST
Location:
Ambac Executive Offices
One State Street Plaza
New York, NY 10004
|
|
AMBAC FINANCIAL GROUP, INC.
ONE STATE STREET PLAZA
NEW YORK, NY 10004
|
You are receiving this communication because you hold shares in the above named company.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
|
|
|
See the reverse side of this notice to obtain
proxy materials and voting instructions.
|
|
Proxy Materials Available to VIEW or RECEIVE:
1. Annual Report 2. Notice & Proxy Statement
How to View Online:
___________
Have the information that is printed in the box marked by the arrow --> /
XXXX XXXX XXXX
/ (located on the following page) and visit:
www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1)
BY INTERNET
: www.proxyvote.com
2)
BY TELEPHONE
: 1-800-579-1639
3)
BY E-MAIL*
: sendmaterial@proxyvote.com
*
If requesting m
aterials by e-mail, p
lease send a blank e-mail with the information that is printed in the box marked
by the arrow --> /
XXXX XXXX XXXX
/ (located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 8, 2014 to facilitate timely delivery.
|
|
|
|
Vote In Person:
Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
Vote By Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow -->
/
XXXX XXXX XXXX
/
available and follow the instructions
.
Vote By Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
Voting Items
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|